InsidersTradesSigma
Discover the complete record of transactions filed by D'Souza Rupert, Chief Financial Officer. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 1 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 13 May 2022. The latest transaction was filed on 13 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
D'Souza Rupert is the Chief Financial Officer of Adverum Biotechnologies, Inc. He oversees the company's financial strategy, including financial planning, risk management, and financial reporting. His role is crucial in ensuring the financial health of the company and supporting its growth and development.